1 / 7

Biomaterials Market worth $207 billion by 2024

Biomaterials Market is projected to grow at a CAGR of 14.5% during the forecast period, to reach USD 207 billion by 2024 from USD 105 billion in 2019.

Download Presentation

Biomaterials Market worth $207 billion by 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. MarketsandMarkets Presents Biomaterials Market Insights on Scope and Growing Demands 2021 https://www.marketsandmarkets.com/Market-Reports/biomaterials- 393.html

  2. ➢ [263 Pages Report] The biomaterials market is projected to reach USD 149.17 Billion by 2021 from USD 70.90 Billion in 2016, at a CAGR of 16.0%. The growth of the overall market can be attributed to increased funds & grants by government bodies worldwide, the growing implantable devices market, technological advancements, rising number of hip and knee replacement procedures, and high growth in geriatric population coupled with growing incidence of cardiovascular diseases. ➢ This report segments the biomaterials market based on type of material, application, and region. On the basis of type of material, the metallic biomaterials segment is expected to account for the largest share of the global market, in 2016; owing to their unique properties such as biocompatibility, strength, and resistance to breakage, which makes them suitable for usage in various medical applications such as orthopedic, cardiovascular, wound healing, and dentistry. The polymeric biomaterials segment is projected to grow at the highest CAGR during the forecast period. This growth can be attributed to the increasing use of polymers in soft tissue applications such as plastic surgeries. https://www.marketsandmarkets.com/Market-Reports/biomaterials- 393.html

  3. Early buyers will receive 10% customization on Reports. https://www.marketsandmarkets.com/Market-Reports/biomaterials- 393.html

  4. ➢ In the coming years, the market is expected to witness the highest growth in the Asia-Pacific region. This can be attributed to factors such as rising cosmetic and plastic surgeries in India, lucrative medical device industry and new tax policy in China, growing number of cardiovascular diseases, increasing aging population, and rising volume of hip and knee replacement procedures in this region. ➢ North America is expected to account for the largest share of the global market, in 2016. Rising biomaterial-based research, increasing demand for plastic surgeries, increasing conferences on biomaterials, growing cancer incidence, and the rising prevalence of cardiovascular diseases are expected to drive market growth in this region. ➢ The biomaterials market is segmented into four major regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Among these regional segments, North America is expected to account for the largest share of the global market, in 2016. However, the Asia- Pacific region is expected to grow at the highest CAGR during the forecast period. The high growth in this regional segment can be attributed to the rising aging population and increasing incidence of cardiovascular and orthopedic diseases in India and China. https://www.marketsandmarkets.com/Market-Reports/biomaterials- 393.html

  5. ➢ Prominent players in the global biomaterials market include Royal DSM (Netherlands), BASF SE (Germany), Corbion Covestro (Germany), Invibio Ltd. (U.K.), Carpenter Corporation (U.S.), Evonik Industries Advanced Biomaterials, Inc. (U.S.), CAM Bioceramics BV (Netherlands), and Celanese Corporation (U.S.). ➢ To speak to our analyst for a discussion on the above findings, click Speak to Analyst N.V. (Netherlands), Technology (Germany), AG Berkeley https://www.marketsandmarkets.com/Market-Reports/biomaterials- 393.html

  6. About MarketsandMarkets MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. https://www.marketsandmarkets.com/Market-Reports/biomaterials- 393.html

  7. Contact Us Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: 1-888-600-6441 Email: sales@marketsandmarkets.com Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/ Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets https://www.marketsandmarkets.com/Market-Reports/biomaterials- 393.html

More Related